COVID-19 Factor Wanes But Pharma’s R&D Pipeline Hits Record Heights
Pipeline Breaks 20,000 Barrier
Pharma’s R&D engine has been firing on all cylinders in the past year – pipeline growth in 2021 stood at nearly twice that for the previous year, pushing the number of products under active development over 20,000 for the first time.
